EGFR and liver cancer: In previous studies of liver cancer cells, the activation of the EGFR signaling pathway with the EGFR ligands, amphiregulin and epiregulin, led to increased LDLR expression through activation of MAPK signaling and a reduction in LDLR mRNA degradation24.